共 12 条
[1]
[2]
老年骨质疏松患者骨折风险因素分析及用药.[J].苏密林;.大家健康(学术版).2014, 05
[3]
[4]
[5]
中国人群骨质疏松诊疗手册(2007年版).[J]..中国骨质疏松杂志.2007, S1
[7]
New developments in biological markers of bone metabolism in osteoporosis.[J].Patrick Garnero.Bone.2014,
[8]
Determinants associated with bone mineral density increase in response to daily teriparatide treatment in patients with osteoporosis.[J].Rui Niimi;Toshibumi Kono;Atsushi Nishihara;Masahiro Hasegawa;Akihiko Matsumine;Toshihiko Kono;Akihiro Sudo.Bone.2014,
[9]
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin.[J].Davide Gatti;Ombretta Viapiana;Silvano Adami;Luca Idolazzi;Elena Fracassi;Maurizio Rossini.Bone.2011, 3
[10]
Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis.[J].Florence Chopin;Emmanuel Biver;Thomas Funck-Brentano;Béatrice Bouvard;Guillaume Coiffier;Patrick Garnero;Thierry Thomas.Joint Bone Spine.2011, 1

